![Chung Iu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chung Iu
Presidente presso Shanghai Mingyuan Enterprise Group Co. Ltd.
Posizioni attive di Chung Iu
Società | Posizione | Inizio | Fine |
---|---|---|---|
HD Global Ltd.
![]() HD Global Ltd. Pharmaceuticals: MajorHealth Technology Part of Mingyuan Medicare Development Co. Ltd., HD Global Ltd. is a Chinese company that researches, develops, and commercializes proteomic products. The company is based in Huzhou, China. HD Global was acquired by Mingyuan Medicare Development Co. Ltd. on July 16, 2003 for $9.81 million. | Direttore/Membro del Consiglio | 19/03/2010 | - |
Shanghai Mingyuan Enterprise Group Co. Ltd. | Direttore/Membro del Consiglio | 15/09/2011 | - |
Presidente | 19/03/2010 | - |
Storia della carriera di Chung Iu
Precedenti posizioni note di Chung Iu
Società | Posizione | Inizio | Fine |
---|---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Direttore/Membro del Consiglio | 27/03/2007 | 15/02/2011 |
Statistiche
Distribuzione geografica
Cina | 3 |
Hong Kong | 2 |
Posizioni
Director/Board Member | 3 |
President | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Mingyuan Medicare Development Co. Ltd.
![]() Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
HD Global Ltd.
![]() HD Global Ltd. Pharmaceuticals: MajorHealth Technology Part of Mingyuan Medicare Development Co. Ltd., HD Global Ltd. is a Chinese company that researches, develops, and commercializes proteomic products. The company is based in Huzhou, China. HD Global was acquired by Mingyuan Medicare Development Co. Ltd. on July 16, 2003 for $9.81 million. | Health Technology |
Shanghai Mingyuan Enterprise Group Co. Ltd. |
- Borsa valori
- Insiders
- Chung Iu
- Esperienza